Literature DB >> 19451292

GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.

Carole Moubareck1, Sylvie Brémont, Marie-Christine Conroy, Patrice Courvalin, Thierry Lambert.   

Abstract

New extended-spectrum beta-lactamase GES-11 was detected in Acinetobacter baumannii BM4674. The enzyme conferred resistance to beta-lactams, including aztreonam, and reduced susceptibility to carbapenems. The structural gene was part of a class 1 integron borne by self-transferable plasmid pIP847. GES-type beta-lactamases have not been reported previously in A. baumannii.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451292      PMCID: PMC2715621          DOI: 10.1128/AAC.00072-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.

Authors:  L Poirel; I Le Thomas; T Naas; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Genetic environment of quinolone resistance gene qnrB2 in a complex sul1-type integron in the newly described Salmonella enterica serovar Keurmassar.

Authors:  Fabien Garnier; Nabil Raked; Amy Gassama; François Denis; Marie-Cécile Ploy
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 4.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 5.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

6.  Molecular characterization of a new class 3 integron in Klebsiella pneumoniae.

Authors:  Mário Correia; Filipa Boavida; Filipa Grosso; M J Salgado; L M Lito; J Melo Cristino; Sónia Mendo; Aida Duarte
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

7.  Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.

Authors:  Sofia Vourli; Panagiota Giakkoupi; Vivi Miriagou; Eva Tzelepi; Alkiviadis C Vatopoulos; Leonidas S Tzouvelekis
Journal:  FEMS Microbiol Lett       Date:  2004-05-15       Impact factor: 2.742

Review 8.  Acinetobacter baumannii: a universal threat to public health?

Authors:  Helen Giamarellou; Anastasia Antoniadou; Kyriaki Kanellakopoulou
Journal:  Int J Antimicrob Agents       Date:  2008-06-20       Impact factor: 5.283

Review 9.  Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

Authors:  Lisa L Maragakis; Trish M Perl
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

10.  Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.

Authors:  Hedi Mammeri; Patrice Nordmann; Amira Berkani; François Eb
Journal:  FEMS Microbiol Lett       Date:  2008-03-27       Impact factor: 2.742

View more
  42 in total

1.  GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.

Authors:  S D Kotsakis; C C Papagiannitsis; E Tzelepi; N J Legakis; V Miriagou; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

2.  Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

Authors:  Aysegul Saral; David A Leonard; Azer Ozad Duzgun; Aysegul Copur Cicek; Cynthia M June; Cemal Sandalli
Journal:  J Antibiot (Tokyo)       Date:  2016-05-11       Impact factor: 2.649

3.  Clinical carbapenem-resistant Acinetobacter baylyi strain coharboring blaSIM-1 and blaOXA-23 from China.

Authors:  Zhihui Zhou; Xiaoxing Du; Li Wang; Qing Yang; Yiqi Fu; Yunsong Yu
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

4.  Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35.

Authors:  Mariana Castanheira; Sarah E Costello; Leah N Woosley; Lalitagauri M Deshpande; Todd A Davies; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

5.  CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp.

Authors:  Laurent Dortet; Laurent Poirel; Caroline Errera; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

Review 6.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.

Authors:  Séverine Bontron; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2015-01-05       Impact factor: 5.191

Review 8.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

9.  Bacteremia due to Acinetobacter genomic species 10.

Authors:  Shu-Chen Kuo; Chang-Phone Fung; Yi-Tzu Lee; Chien-Pei Chen; Te-Li Chen
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

10.  Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases.

Authors:  Heinrich Delbrück; Pierre Bogaerts; Michaël B Kupper; Roberta Rezende de Castro; Sandra Bennink; Youri Glupczynski; Moreno Galleni; Kurt M Hoffmann; Carine Bebrone
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.